Showing 141 - 160 of 737 results
A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.
On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
ANSTO User Meeting 2021 - Speakers
Accurate ‘fingerprinting’ tool to verify source of origin is in development with collaborators from academia and industry.
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
Part of the Large Hardon Collider
On behalf of Australia, ANSTO, the only nuclear reactor facility in Australia, supports the International Atomic Energy Agency (IAEA) to undertake its role in facilitating national, regional, and international efforts to enhance nuclear security, including measures to protect against nuclear terrorism.
Insights about Mayan Empire relevant for current climate challenges
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.
Your efforts are helping better manage our wetlands and waterways, and protect the precious wetland birds that rely on them.